REDWOOD CITY, Calif.--(BUSINESS WIRE)--A new publication this month in the Annals of the American Thoracic Society confirms the effectiveness of the Zephyr Valve ® in improving dyspnea (shortness of ...
Pulmonx ® Corp. announced today that the U.S. Food and Drug Administration (FDA) has approved the Zephyr ® Endobronchial Valve System for treating severe emphysema patients. The Zephyr Valve is the ...
SAN DIEGO & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx® Corp. today announced positive one-year results from the U.S. LIBERATE pivotal trial of the Zephyr® Endobronchial Valve, a ...
PHOENIX - Banner University Medicine Lung Institute is the first in Arizona and second in the U.S. to offer a new lung valve treatment for patients with severe COPD or emphysema. Recently approved by ...
INDIANAPOLIS (WTHR) - Marie Weiss is the first patient at IU Health to undergo an endobronchial valve procedure. Only recently approved by the FDA, she says it's been life-changing. Weiss was ...
Symptoms of dyspnea in a patient with chronic obstructive pulmonary disease (COPD), which were caused by pulmonary hyperinflation, were improved by endobronchial valve treatment. Endobronchial valve ...
CHILLICOTHE— A new, minimally invasive procedure now being offered by Adena Health System for patients suffering from emphysema and COPD. “We’ve actually been talking about doing this type of ...
The US Food and Drug Administration (FDA) has approved the Zephyr Endobronchial Valve (Pulmonx Corp) to treat breathing difficulty associated with severe emphysema. "Treatment options are limited for ...
The approval was based on results from a multicenter study (LIBERATE) of 190 patients with severe emphysema. The Food and Drug Administration (FDA) has approved the Zephyr Endobronchial Valve (Pulmonx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results